Tag Archives: NIH

dan-dixon-med-research.jpg

What the Government Shutdown Means for Colorectal Cancer

After 15 days, most of us have seen at least one way the government shutdown is impacting our country. Some have friends and family members on furlough who’ve finally had time to paint their bathrooms. Others’ vacation plans are ruined since national monuments and parks are closed. But the ripples of the shutdown go beyond closings, halted jobs and a growing annoyance with our country’s leaders. The shutdown is impacting cancer patients and researchers across the globe and hope for a cure. The Government and Cancer Research Last week the Washington Post ran a front-page story about a beautiful young mom whose treatment for sarcoma is halted because of the

What’s Happening on Capitol Hill? May 2013 Update

Dear Advocates, Your efforts are making an impact. Every time you exercise your right as a US citizen to communicate with Congress, you are changing the landscape for colorectal cancer patients. We applaud you for your passion and advocacy. Has Your Representative Cosponsored H.R. 1070? ACTION REQUESTED Rep. Charlie Dent (R-PA) introduced on March 15 the “Removing Barriers to Colorectal Cancer Screening Act,” (H.R. 1070).The bill would waive Medicare beneficiary coinsurance for colorectal cancer screening colonoscopy when a polyp is removed.  As of May 16, the bill had 28 cosponsors. To find out if your representative has cosponsored H.R. 1070 go to www.thomas.gov and search by bill number.  If your

Statement from Carlea Bauman, President of Fight Colorectal Cancer, Regarding the President’s 2014 Budget

I am deeply disappointed that President Obama’s fiscal year (FY) 2014 budget would strip nearly $4 million from the Centers for Disease Control and Prevention’s (CDC) Colorectal Cancer Control Program. The CDC estimates that the loss of funding will mean at least five fewer programs (out of the current 29) working to prevent colorectal cancer. The president’s budget assumes that less federal funding is needed for direct screenings, such as colorectal, breast, and cervical screenings, because most health plans are required to cover these screenings without co-pays or deductibles, and because, starting in 2014, the Affordable Care Act ensures that no one can be denied health insurance because of a

Getting Ready to Rally Again – Rally For Medical Research

OOOOh there’s something about a good ole’ fashioned Washington, DC rally that really gets us going. Next Monday you will find Fight Colorectal Cancer standing alongside many other health-focused non-profits at the Rally for Medical Research. Why? Well, we do have a thing for The Hill. But we’re participating to show our government that we too have a dream – a county that invests in a cure for colorectal cancer and supports medical research. If you’re in or around the DC area Monday, April 8, join us at the Rally for Medical Research. If you’re not around – keep reading for how you can get involved! You don’t have to

Fighting Crisis in Cancer Funding Named Number One Priority for AACR

The American Association for Cancer Research (AACR) says that declining budgets at the National Institutes of Health a crisis standing in the way of bringing cancer research to patient’s lives. For the past ten years, NIH budgets have been essentially flat.  Factoring in rising research costs, flat funding means a loss of nearly $6 billion dollars in purchasing power. AACR is calling on its members and the advocacy community to work even harder with Congress to invest in medical research.  The AACR board of directors said, Therefore, the AACR announced this morning that it plans to redouble its efforts to engage with Congress to make research funding a higher national

Dr. Francis Collins Confirmed as NIH Head

On Friday, August 7, the Senate unanimously confirmed the appointment of Francis Collins, MD, PhD, as the new director of the National Institutes of Health. Dr. Collins is both a physician and an expert in genetics.  He led the Human Genome Project to an early success in identifying and sequencing the 25,000 genes in the human genome and headed the National Human Genome Research Institute (NHGRI) from 1993 through 2008.

C3 President Speaks at NIH Meeting on Expansion of ClinicalTrials.Gov

Carlea Bauman, President of C3: Colorectal Cancer Coalition spoke today. April 20, 2009, at a public meeting called by the National Institutes of Health to hear input on expansion of its clinical trials registry. In calling for the ClinicalTrials.Gov database to include results of all clinical trials, Bauman said, C3:Colorectal Cancer Coalition is committed to providing results of clinical trials that affect patients with colon and rectal cancer fairly and honestly, providing both positive and negative conclusions, and helping patients to understand what the results mean to them in language they can understand.

Top